Gemfibrozil
Klinički podaci
Robne marke
Bolutol, Cholespid, Decrelip, Fibratol
AHFS/Drugs.com
Monografija
Identifikatori
CAS broj
25812-30-0
ATC kod
C10 AB04
PubChem [ 1] [ 2]
3463
DrugBank
DB01241
ChemSpider [ 3]
3345
ChEBI
CHEBI:5296 Y
ChEMBL [ 4]
CHEMBL457 Y
Hemijski podaci
Formula
C 15 H 22 O 3
Mol. masa
250,333
SMILES
eMolekuli &PubHem
InChI
InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17) Key: HEMJJKBWTPKOJG-UHFFFAOYSA-NY
Fizički podaci
Tačka topljenja
62 °C (144 °F)
Tačka ključanja
158.5 °C (317 °F)
Farmakokinetički podaci
Poluvreme eliminacije
1,5 h
Izlučivanje
Renalno
Farmakoinformacioni podaci
Trudnoća
?
Pravni status
Način primene
Oralno
Gemfibrozil jeorgansko jedinjenje ,koje sadrži 15atoma ugljenika i imamolekulsku masu od 250,333Da .[ 5] [ 6]
↑ Li Q, Cheng T, Wang Y, Bryant SH (2010).„PubChem as a public resource for drug discovery.” .Drug Discov Today 15 (23-24): 1052-7.DOI :10.1016/j.drudis.2010.10.003 .PMID 20970519 . edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry 4 :217-241.DOI :10.1016/S1574-1400(08)00012-1 .
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010).„Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining” .J Cheminform 2 (1): 3.DOI :10.1186/1758-2946-2-3 .PMID 20331846 . edit
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res 40 (Database issue): D1100-7.DOI :10.1093/nar/gkr777 .PMID 21948594 . edit
↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011).„DrugBank 3.0: a comprehensive resource for omics research on drugs” .Nucleic Acids Res. 39 (Database issue): D1035-41.DOI :10.1093/nar/gkq1126 .PMC 3013709 .PMID 21059682 .
↑ David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008).„DrugBank: a knowledgebase for drugs, drug actions and drug targets” .Nucleic Acids Res 36 (Database issue): D901-6.DOI :10.1093/nar/gkm958 .PMC 2238889 .PMID 18048412 .
↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998).„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods” .J. Phys. Chem. A 102 :3762-3772.DOI :10.1021/jp980230o .
↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001).„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices” .Chem Inf. Comput. Sci. 41 :1488-1493.DOI :10.1021/ci000392t .PMID 11749573 .
↑ Ertl P., Rohde B., Selzer P. (2000).„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties” .J. Med. Chem. 43 :3714-3717.DOI :10.1021/jm000942e .PMID 11020286 .